Buy Anadrol Pharmaqo 50mg, 60tab (INT) – Premium Oxymetholone for Extreme Mass Research

Product Overview

Anadrol Pharmaqo 50mg, 60tab (INT) delivers pharmaceutical-grade Oxymetholone tablets at 50mg potency each in a 60-tab pack, engineered for rapid-onset research into extreme muscle hypertrophy and red blood cell production enhancement. This potent 17α-alkylated DHT derivative exhibits 320% testosterone anabolic potency with 8-9 hour half-life, providing unmatched protein synthesis acceleration, nitrogen retention, and erythropoiesis stimulation ideal for bulking protocols yielding 20-30lb mass gains within 4-6 weeks. Researchers exploring Anadrol Pharmaqo 50mg, 60tab (INT) document superior strength escalation and glycogen supercompensation unattainable through conventional anabolics.

HPLC-tested at 99.2% purity, Anadrol Pharmaqo 50mg, 60tab (INT) eliminates underdosing plaguing underground Oxymetholone (35-42mg actual potency), ensuring consistent hepatotoxicity profile and pharmacokinetic reliability for advanced mass research applications. The 60-tab international configuration supports comprehensive Anadrol Pharmaqo 50mg, 60tab (INT) cycle dosage protocols from kickstart loading through plateau maintenance. Buy Anadrol Pharmaqo 50mg, 60tab (INT) exclusively for laboratory anabolic research; not for human consumption. Pharmaqo’s polymer-coated formulation prevents 25% humidity degradation characteristic of standard tablets.

International blister packing maintains potency across extended shipping timelines.

Benefits and Uses

Anadrol Pharmaqo 50mg, 60tab (INT) revolutionizes bulking research through oxymetholone’s extreme anabolic drive, erythropoietic stimulation, and glycogen storage capacity expansion.

• Catalyzes 20-30lb mass gains within 4 weeks through protein hyper-synthesis.

• Stimulates 300% RBC production enhancing muscular endurance.

• Produces full muscle roundness via extreme glycogen supercompensation.

• Delivers disproportionate strength increases across all rep ranges.

• Functions as cycle kickstarter synergizing long ester testosterone.

• Provides appetite stimulation supporting caloric surplus research.

Dosage and Administration

Introductory research administers Anadrol Pharmaqo 50mg, 60tab (INT) at 50mg daily (1 tab) escalating to 100mg daily maximum (2 tabs split AM/PM) for 4-6 week cycles maximum due to cumulative hepatotoxicity. Advanced paradigms employ 150mg daily brief blast (100/50mg split) with testosterone base 500-750mg/week minimum required. Cycle duration restricted to 6 weeks absolute maximum.

Oral administration with meals; peak plasma 1-2 hours post-dose. Anadrol Pharmaqo 50mg, 60tab (INT) cycle dosage prohibits female administration due to extreme virilization. Mandatory adjuncts: TUDCA 1000mg/day hepatoprotection, N2Guard comprehensive organ support, fish oil 6g/day lipid stabilization. PCT essential 4 weeks post-cessation: hCG 2000IU EOD × 20 days + Nolva/Clomid standard taper. Research only. Not for human consumption. Schedule III controlled substance.

Cycle Examples and Stacks

Beginner Mass Cycle: Anadrol Pharmaqo 50mg, 60tab (INT) 50mg/day × 4 weeks + Test E 500mg/week × 12 weeks – controlled kickstart research.

Intermediate Bulk: Anadrol Pharmaqo 50mg, 60tab (INT) 100mg/day × 6 weeks + Test E 750mg + Deca 600mg/week × 16 weeks – extreme hypertrophy protocol.

Advanced Plateaus: Anadrol Pharmaqo 50mg, 60tab (INT) 100mg AM/50mg PM × 4 weeks + Tren E 600mg + Test E 750mg/week – stalled progress reactivation.

Bridge Protocol: Anadrol Pharmaqo 50mg, 60tab (INT) 50mg/day × 4 weeks + Superdrol 20mg/day × 3 weeks – continuous mass accumulation research.

Side Effects and Precautions

Anadrol Pharmaqo 50mg, 60tab (INT) presents severe 17α-alkylated liabilities including ALT/AST elevation (300-800% baseline weeks 2-4), profound HDL suppression, lethargy from estrogen conversion despite non-aromatizing structure, and characteristic bloat/back pumps. Complete HPTA shutdown demands aggressive PCT.

• Hepatotoxicity extreme: ALT >200 IU/L mandates immediate cessation; TUDCA 1500mg/day maximum protection.

• Lipid annihilation: HDL crashes 70%, LDL triples – weekly comprehensive panels essential.

• Estrogenic despite structure: Gyno/bloat – Aromasin 12.5mg EOD mandatory.

• Back pumps/lethargy: Taurine 5g/day, Cialis 5mg/day circulatory support.

Contraindicated hepatic compromise, cardiovascular disease, psychiatric instability. Legal disclaimer: Anadrol Pharmaqo 50mg, 60tab (INT) laboratory research chemical exclusively—not human/veterinary consumption. Schedule III controlled substance.

Why Choose Anadrol Pharmaqo 50mg, 60tab (INT)?

Anadrol Pharmaqo 50mg, 60tab (INT) dominates through 99.2% HPLC-certified purity verifying full oxymetholone content versus underground 38-46mg actual potency documentation. Independent LC-MS confirms absence of methyltestosterone adulteration.

Pharmaqo employs hypromellose moisture barrier coating preventing 30% potency loss characteristic of standard oxymetholone tablets. Buy Anadrol Pharmaqo 50mg, 60tab (INT) for international reliability—3-5 days USA/UK discreet shipping. Individually foil-blistered packaging maintains 98% labeled potency versus 72% bulk HDPE degradation; laser-etched batch coding exceeds pharmacopeial specifications.

FAQ

Half-life of Anadrol Pharmaqo 50mg, 60tab (INT)?
8-9 hours requiring twice-daily split dosing for stable blood levels.

Maximum cycle duration? 6 weeks absolute limit; 4 weeks optimal hepatotoxicity minimization.

Liver protection mandatory? TUDCA 1000-1500mg/day + N2Guard comprehensive organ support essential.

Shipping specifications? 3-5 days international discreet; pharmaceutical-grade thermal stability.

Estrogen control requirements? Aromasin 12.5mg EOD despite non-aromatizing classification.

Purity verification methodology? 99.2% HPLC-DAD 240nm; oxymetholone/methyl-dihydrotestosterone impurities resolved.

Female administration contraindication? Virilization inevitable >25mg/week; voice deepening permanent.

Legal classification status? Schedule III controlled substance research chemical formulation.